How much funding has CancerIQ raised?

CancerIQ has raised $26.3M in total funding, most recently a Growth Equity round.

Who are CancerIQ's investors?

CancerIQ's investors include HealthX Ventures, Decathlon Capital Partners, Merck Global Health Innovation Fund, Amgen, McKesson Ventures, OSF Ventures.

Where is CancerIQ headquartered?

CancerIQ is headquartered in Chicago, United States.

What industry is CancerIQ in?

CancerIQ operates in Healthcare, SaaS.

CancerIQ

Let's end cancer as we know it.

Chicago, United States · Founded 2014 · $26.3M raised

Healthcare

SaaS

Headquarters: Chicago
Employees: 51–200
Founded: 2014
Business Model: B2B

Website: canceriq.com
Total Funding: $26.3M
Last Round: $14.0M Growth EquityAug 2024
Rounds: 5

About

CancerIQ is a digital health technology platform founded in 2014 and headquartered in Chicago, Illinois, that helps hospitals and health systems scale precision cancer prevention and early detection programs. The platform automates patient risk stratification using evidence-based guidelines like NCCN and Tyrer-Cuzick, streamlines genetic counseling and testing workflows, generates pedigrees and insurance pre-authorizations, and manages high-risk patient cohorts over time with automated care reminders. CancerIQ is implemented in over 200 clinic locations across the United States and serves a range of clinical settings from oncology programs to genetics and breast programs.

Summary

CancerIQ is a Healthcare company based in Chicago, United States, founded in 2014. It has raised $26.3M in total across 5 rounds, most recently a $14.0M Growth Equity round in Aug 2024. Investors include HealthX Ventures, Decathlon Capital Partners and Merck Global Health Innovation Fund.

LinkedIn X (Twitter)